Your browser doesn't support javascript.
loading
Single-Agent Regorafenib in Metastatic Colorectal Cancer Patients with Any RAS or BRAF Mutation Previously Treated with FOLFOXIRI plus Bevacizumab (PREVIUM Trial).
García-Alfonso, Pilar; Benavides, Manuel; Falcó, Esther; Muñoz, Andrés; Gómez, Auxiliadora; Sastre, Javier; Rivera, Fernando; Montagut, Clara; Salgado, Mercedes; López-Ladrón, Amelia; López, Rafael; Ruiz de Mena, Inmaculada; Durán, Gema; Aranda, Enrique.
Afiliação
  • García-Alfonso P; Medical Oncology Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain pgarcaalfonso@gmail.com.
  • Benavides M; Medical Oncology Department, Hospital Universitario Regional y Virgen de la Victoria, Málaga, Spain.
  • Falcó E; Clinical Oncology Department, Hospital Son Llatzer, Palma de Mallorca, Spain.
  • Muñoz A; Medical Oncology Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
  • Gómez A; IMIBIC, Hospital Reina Sofía, University of Córdoba, Córdoba, Andalusia, Spain.
  • Sastre J; CIBERONC Instituto de Salud Carlos III, Madrid, Spain.
  • Rivera F; Medical Oncology Department, Hospital Universitario Clinico San Carlos, Madrid, Spain.
  • Montagut C; Instituto de Investigación Hospital Clinico San Carlos (IdISSC), University Complutense, CIBERONC, Madrid, Spain.
  • Salgado M; Clinical Oncology Service, Hospital Universitario Marqués de Valdecilla, Santander, Spain.
  • López-Ladrón A; Medical Oncology Department, Hospital del Mar, Barcelona, Spain.
  • López R; Clinical Oncology Service, C.H. Universitario, Orense, Spain.
  • Ruiz de Mena I; Medical Oncology Department, Hospital Nuestra Senora de Valme, Sevilla, Spain.
  • Durán G; Medical Oncology Department, Hospital Clínico de Santiago de Compostela, CIBERONC, La Coruña, Spain.
  • Aranda E; Spanish Cooperative Group for the Treatment of Digestive Tumors (TTD), Madrid, Spain.
Oncologist ; 23(11): 1271-e128, 2018 11.
Article em En | MEDLINE | ID: mdl-30120161

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Compostos de Fenilureia / Piridinas / Camptotecina / Neoplasias Colorretais / Protocolos de Quimioterapia Combinada Antineoplásica / Proteínas ras / Proteínas Proto-Oncogênicas B-raf / Bevacizumab / Antineoplásicos Imunológicos Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Compostos de Fenilureia / Piridinas / Camptotecina / Neoplasias Colorretais / Protocolos de Quimioterapia Combinada Antineoplásica / Proteínas ras / Proteínas Proto-Oncogênicas B-raf / Bevacizumab / Antineoplásicos Imunológicos Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2018 Tipo de documento: Article